The research aims to design a targeted theranostic nanoagent that assists in the surgical removal of oral squamous cell carcinoma (OSCC).
Developing a nanoagent for imaging and treatment.
Testing the nanoagent in preclinical models.
Assessing its efficacy in aiding tumor removal during surgery.
The nanoagent successfully identified tumor margins.
Significantly improved the rate of complete tumor removal during simulated surgeries.
Abstract
Oral squamous cell carcinoma (OSCC) is a common cancer of the head and neck, and its treatment outcome depends strongly on whether the tumor is completely removed during surgery.